{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:37:06Z","timestamp":1791250626809,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T00:00:00Z","timestamp":1437091200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1516-2","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T05:58:26Z","timestamp":1437026306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Spectrum and frequencies of BRCA1\/2 mutations in Bulgarian high risk breast cancer patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Rumyana Ivanova","family":"Dodova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanaska Velichkova","family":"Mitkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Rosenova","family":"Dacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina Basam","family":"Hadjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandrina Ivanova","family":"Vlahova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita Stoyanova Taushanova","family":"- Hadjieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spartak Stoyanov","family":"Valev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija Mitko","family":"Caulevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislava Dimitrova","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Emilov","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tihomir Iliichev","family":"Dikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theophil Angelov","family":"Sedloev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanas Stefanov","family":"Ionkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanta Velinova","family":"Timcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana Liubomirova","family":"Christova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo Marinov","family":"Kremensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanio Ivanov","family":"Mitev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka Petrova","family":"Kaneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,17]]},"reference":[{"key":"1516_CR1","unstructured":"GLOBOCAN 2012: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx. Accessed 23 Jan 2015."},{"key":"1516_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66\u201371.","journal-title":"Science"},{"key":"1516_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789\u201392.","journal-title":"Nature"},{"issue":"3","key":"1516_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2013.2541","volume":"30","author":"H Kobayashi","year":"2013","unstructured":"Kobayashi H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (Review). Oncol Rep. 2013;30(3):1019\u201329.","journal-title":"Oncol Rep"},{"key":"1516_CR5","doi-asserted-by":"crossref","first-page":"vi31","DOI":"10.1093\/annonc\/mdr373","volume":"6","author":"J Balma\u00f1a","year":"2011","unstructured":"Balma\u00f1a J, D\u00edez O, Rubio IT, Cardoso F, ESMO Guidelines Working Group. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol Suppl. 2011;6:vi31\u2013vi4.","journal-title":"Ann Oncol Suppl"},{"issue":"5","key":"1516_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected incase series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72(5):1117\u201330.","journal-title":"Am J Hum Genet"},{"key":"1516_CR7","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1038\/bjc.2013.144","volume":"108","author":"EH Lips","year":"2013","unstructured":"Lips EH, Mulder L, Oonk A, van der Kolk LE, Hogervorst FBL, Imholz ALT, et al. Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers. Br J Cancer. 2013;108:2172\u20137.","journal-title":"Br J Cancer"},{"issue":"11","key":"1516_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al. EMBRACE. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105(11):812\u201322.","journal-title":"J Natl Cancer Inst"},{"key":"1516_CR9","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/hmg\/4.suppl_1.1811","volume":"4","author":"CI Szabo","year":"1995","unstructured":"Szabo CI, King MC. Inherited breast and ovarian cancer. Hum Mol Genet. 1995;4:1811\u20137.","journal-title":"Hum Mol Genet"},{"key":"1516_CR10","unstructured":"Breast Cancer Information Core. http:\/\/www.nhgri.nih.gov\/Intramural_research\/Lab_transfer\/BIC 1997. Accessed 23 Jan 2015."},{"issue":"12","key":"1516_CR11","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA. 2006;295(12):1379\u201388.","journal-title":"JAMA"},{"issue":"66","key":"1516_CR12","first-page":"445","volume":"12","author":"SA Narod","year":"2011","unstructured":"Narod SA, Salmena L. BRCA1 and BRCA2 mutations and breast cancer. Discov Med. 2011;12(66):445\u201353.","journal-title":"Discov Med"},{"issue":"3","key":"1516_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavi\u010dius","year":"2010","unstructured":"Janavi\u010dius R. Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J. 2010;1(3):397\u2013412.","journal-title":"EPMA J"},{"issue":"3","key":"1516_CR14","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s11033-011-0958-0","volume":"39","author":"F Wang","year":"2012","unstructured":"Wang F, Fang Q, Ge Z, Yu N, Xu S, Fan X. Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review. Mol Biol Rep. 2012;39(3):2109\u201318.","journal-title":"Mol Biol Rep"},{"key":"1516_CR15","unstructured":"Dimitrova N, Petkova Y, Uzunova L, Yordanova M, Tonev S, Grozeva T, et al. Cancer Incidence in Bulgaria 2011. In: National Oncological Hospital. Bulgarian National Cancer Register. Volume XXII. Edited by Dimitrova N, Vukov M, Valerianova Z. Paradigma; 2013: p.92, 146\u2013149."},{"issue":"2","key":"1516_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/sj.ejhg.5200171","volume":"6","author":"A Markoff","year":"1998","unstructured":"Markoff A, Sormbroen H, Bogdanova N, Preisler-Adams S, Ganev V, Dworniczak B, et al. Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. Eur J Hum Genet. 1998;6(2):145\u201350.","journal-title":"Eur J Hum Genet"},{"key":"1516_CR17","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"Breast Cancer Linkage Consortium","year":"1999","unstructured":"Breast Cancer Linkage Consortium. Cancer Risks in BRCA2 Mutation Carriers. J Natl Cancer Inst. 1999;91:1310\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"1516_CR18","unstructured":"Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, et. al., National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology 2010: Genetic\/ familial high risk assessment: breast and ovarian. Version I. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/genetics_screening.pdf. Accessed 22 Nov 2010."},{"key":"1516_CR19","unstructured":"ExonPrimer. http:\/\/ihg.gsf.de\/ihg\/ExonPrimer.html. Accessed 10 Dec 2008."},{"key":"1516_CR20","unstructured":"National Center for Biotechnology Information Blast. http:\/\/www.ncbi.nlm.nih.gov\/BLAST\/. Accessed 02 July 2013."},{"key":"1516_CR21","unstructured":"PolyPhen 2. http:\/\/genetics.bwh.harvard.edu\/pph2\/. Accessed 10 Jan 2015."},{"key":"1516_CR22","unstructured":"SIFT. http:\/\/sift.jcvi.org\/. Accessed 15 Apr 2013."},{"key":"1516_CR23","unstructured":"PROVEAN. http:\/\/provean.jcvi.org\/index.php. Accessed 15 Apr 2013."},{"key":"1516_CR24","unstructured":"National Center for Biotechnology Information SNP. \nhttp:\/\/www.ncbi.nlm.nih.gov\/SNP\/. Accessed 02 Apr 2015."},{"issue":"3","key":"1516_CR25","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1158\/0008-5472.CAN-09-2850","volume":"70","author":"DJ Ransburgh","year":"2010","unstructured":"Ransburgh DJ, Chiba N, Ishioka C, Toland AE, Parvin JD. Identification of breast tumour mutations in BRCA1 that abolish its function in homologous DNA recombination. Cancer Res. 2010;70(3):988\u201395.","journal-title":"Cancer Res"},{"key":"1516_CR26","unstructured":"Universal Mutation Database. http:\/\/www.umd.be\/LSDB.html. Accessed 15 Jan 2015."},{"key":"1516_CR27","unstructured":"Leiden Open Variation Database. http:\/\/chromium.liacs.nl\/LOVD2\/cancer\/home.php. Accessed 15 Jan 2015."},{"issue":"3","key":"1516_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10549-007-9571-2","volume":"107","author":"I Konstantopoulou","year":"2008","unstructured":"Konstantopoulou I, Rampias T, Ladopoulou A, Koutsodontis G, Armaou S, Anagnostopoulos T, et al. Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high\u2013risk breast\/ovarian cancer patients. Breast Cancer Res Treat. 2008;107(3):431\u201341.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1516_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10689-010-9361-6","volume":"9","author":"L Negura","year":"2010","unstructured":"Negura L, Uhrhammer N, Negura A, Artenie V, Carasevici E, Bignon YJ. Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population. Fam Cancer. 2010;9(4):519\u201323.","journal-title":"Fam Cancer"},{"issue":"5","key":"1516_CR30","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.7314\/APJCP.2013.14.5.3229","volume":"14","author":"H Haytural","year":"2013","unstructured":"Haytural H, Yalcinkaya N, Akan G, Arikan S, Ozkok E, Cakmakoglu B, et al. Identification of a novel BRCA2 and CHEK2 A-C-G-C haplotype in Turkish patients affected with breast cancer. Asian Pacific J Cancer Prev. 2013;14(5):3229\u201335.","journal-title":"Asian Pacific J Cancer Prev"},{"key":"1516_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/jhg.2013.30","volume":"58","author":"J Dobri\u010di\u0107","year":"2013","unstructured":"Dobri\u010di\u0107 J, Krivoku\u0107a A, Brotto K, Mali\u0161i\u0107 E, Radulovi\u0107 S, Brankovi\u0107-Magi\u0107 M. Serbian high-risk families: extensive results on BRCA mutation spectra and frequency. J Hum Genet. 2013;58:501\u20137.","journal-title":"J Hum Genet"},{"issue":"2","key":"1516_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.gene.2012.02.010","volume":"498","author":"S Levanat","year":"2012","unstructured":"Levanat S, Musani V, Cvok ML, Susac I, Sabol M, Ozretic P, et al. Three novel BRCA1\/BRCA2 mutations in breast\/ovarian cancer families in Croatia. Gene. 2012;498(2):169\u201376.","journal-title":"Gene"},{"issue":"Supplement","key":"1516_CR33","first-page":"81","volume":"15","author":"I Maleva","year":"2012","unstructured":"Maleva I, Madjunkova S, Bozhinovski G, Smickova E, Kondov G, Spiroski Z, et al. Genetic variation of the BRCA1 and BRCA2 genes in Macedonian patients. BJMG. 2012;15(Supplement):81\u20135.","journal-title":"BJMG"},{"issue":"3","key":"1516_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ejhg.2010.203","volume":"19","author":"N Hamel","year":"2010","unstructured":"Hamel N, Feng BJ, Foretova L, Stoppa-Lyonnet D, Narod SA, Imyanitov E, et al. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations. Eur J Hum Genet. 2010;19(3):300\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1516_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.26369","volume":"131","author":"J Lubinski","year":"2012","unstructured":"Lubinski J, Huzarski T, Byrski T, Lynch HT, Cybulski C, Ghadirian P, et al. The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Int J Cancer. 2012;131(1):229\u201334.","journal-title":"Int J Cancer"},{"issue":"3","key":"1516_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10689-012-9590-y","volume":"12","author":"A Chakraborty","year":"2013","unstructured":"Chakraborty A, Mukhopadhyay A, Bhattacharyya D, Bose CK, Choudhuri K, Mukhopadhyay S, et al. Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India. Fam Cancer. 2013;12(3):489\u201395.","journal-title":"Fam Cancer"},{"issue":"12","key":"1516_CR37","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/jama.279.12.922","volume":"279","author":"KE Malone","year":"1998","unstructured":"Malone KE, Daling JR, Thompson JD, O\u2019Brien CA, Francisco LV, Ostrander EA. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA. 1998;279(12):922\u20139.","journal-title":"JAMA"},{"issue":"2","key":"1516_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/jhg.2011.142","volume":"57","author":"WH Kuo","year":"2012","unstructured":"Kuo WH, Lin PH, Huang AC, Chien YH, Liu TP, Lu YS, et al. Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer. J Hum Genet. 2012;57(2):130\u20138.","journal-title":"J Hum Genet"},{"issue":"2","key":"1516_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4067\/S0716-97602012000200003","volume":"45","author":"K Lara","year":"2012","unstructured":"Lara K, Consigliere N, P\u00e9rez J, Porco A. BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela. Biol Res. 2012;45(2):117\u201330.","journal-title":"Biol Res"},{"issue":"4","key":"1516_CR40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1399-0004.2010.01473.x","volume":"78","author":"NV Bogdanova","year":"2010","unstructured":"Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Hillemanns P, D\u00f6rk T. High frequency and allelespecific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus. Clin Genet. 2010;78(4):364\u201372.","journal-title":"Clin Genet"},{"issue":"3","key":"1516_CR41","first-page":"215","volume":"12","author":"VM De Benedetti","year":"1998","unstructured":"De Benedetti VM, Radice P, Pasini B, Stagi L, Pensotti V, Mondini P, et al. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and\/or ovarian carcinoma patients. Hum Mutat. 1998;12(3):215\u20139.","journal-title":"Hum Mutat"},{"key":"1516_CR42","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1007\/s12032-012-0294-9","volume":"29","author":"A Juwle","year":"2012","unstructured":"Juwle A, Saranath D. BRCA1\/BRCA2 gene mutations\/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity. Med Oncol. 2012;29:3272\u201381.","journal-title":"Med Oncol"},{"issue":"2","key":"1516_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","volume":"121","author":"S Zhang","year":"2011","unstructured":"Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA, et al. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol. 2011;121(2):353\u20137.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"1516_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jmg.38.6.361","volume":"38","author":"JT Bergthorsson","year":"2001","unstructured":"Bergthorsson JT, Ejlertsen B, Olsen JH, Borg A, Nielsen KV, Barkardottir RB, et al. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet. 2001;38(6):361\u20138.","journal-title":"J Med Genet"},{"issue":"6","key":"1516_CR45","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ijc.10289","volume":"98","author":"E Kwiatkowska","year":"2002","unstructured":"Kwiatkowska E, Teresiak M, Breborowicz D, Mackiewicz A. Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer. Int J Cancer. 2002;98(6):943\u20135.","journal-title":"Int J Cancer"},{"issue":"1","key":"1516_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/humu.21627","volume":"33","author":"NM Lindor","year":"2012","unstructured":"Lindor NM, Guidugli L, Wang X, Vall\u00e9e MP, Monteiro AN, Tavtigian S, et al. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat. 2012;33(1):8\u201321.","journal-title":"Hum Mutat"},{"issue":"Suppl 7","key":"1516_CR47","doi-asserted-by":"crossref","first-page":"vii30-v","DOI":"10.1093\/annonc\/mdl946","volume":"17","author":"C Augello","year":"2006","unstructured":"Augello C, Bruno L, Bazan V, Cal\u00f2 V, Agnese V, Corsale S, et al. Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell\u2019Italia Meridionale) prospective study. Ann Oncol. 2006;17 Suppl 7:vii30-v.","journal-title":"Ann Oncol"}],"updated-by":[{"DOI":"10.1186\/s12885-017-3188-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1516-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1516-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T17:14:12Z","timestamp":1630602852000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1516-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1516-2","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-017-3188-6","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,17]]},"assertion":[{"value":"4 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"523"}}